Page last updated: 2024-10-27

gemfibrozil and Uremia

gemfibrozil has been researched along with Uremia in 2 studies

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research Excerpts

ExcerptRelevanceReference
" In 55 patients (20 on HD, 13 on CAPD and 22 NDCRF) with severe hypertriglyceridemia or diminished HDL cholesterol gemfibrozil 300 mg b."3.68Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil. ( Dardamanis, MA; Elisaf, MS; Papagalanis, ND; Siamopoulos, KC, 1993)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elisaf, MS1
Dardamanis, MA1
Papagalanis, ND1
Siamopoulos, KC1
Lucatello, A1
Sturani, A1
Di Nardo, AM1
Cocchi, R1
Fusaroli, M1

Other Studies

2 other studies available for gemfibrozil and Uremia

ArticleYear
Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil.
    Scandinavian journal of urology and nephrology, 1993, Volume: 27, Issue:1

    Topics: Adult; Aged; Cholesterol, HDL; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; H

1993
Safe use of gemfibrozil in uremic patients on continuous ambulatory peritoneal dialysis.
    Nephron, 1998, Volume: 78, Issue:3

    Topics: Aged; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Periton

1998